PAAS.TO (PAAS.TO)

$30.0B
Market Cap
20.2
P/E Ratio
1.44
Beta
1.04%
Dividend Yield
Piotroski 7/9Altman Z 7.5 SafeBeneish M 1.16 Flag (> −2.22)ROIC−WACC -1.9%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 7.5 (above 3.0 safe zone threshold). Beneish M-Score of 1.16 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency presents a notable divergence from the reported profitability metrics. While the DuPont decomposition reveals a robust return on equity of 14.0% driven primarily by expansive net margins at 27.0%, this operational leverage is counterbalanced by a negative ROIC-WACC spread of -1.9%. This indicates that despite high margin generation, the cost of capital currently exceeds the returns generated on invested assets, suggesting potential inefficiencies in asset utilization relative to financing costs. However, fundamental quality signals remain strong; the company exhibits a Piotroski F-Score of 7/9 and an Altman Z-Score of 7.5, indicating robust financial health with low distress probability, while revenue growth accelerates at 28.4% year-over-year.

Valuation dynamics appear stretched relative to intrinsic value models but are supported by recent insider positioning. The current P/E ratio of 20.2x sits significantly above the DCF-derived fair value estimate of $57 per share, implying that market pricing assumes a growth trajectory or margin expansion not fully captured in the base case model. This premium valuation is partially offset by substantial insider conviction, evidenced by $5.4 million in net buying over the last 90 days, which often signals management confidence in future operational execution despite current capital efficiency headwinds.

Risk assessment relies heavily on the quality of earnings and the sustainability of margin expansion given the negative spread between returns and cost of capital. The low Beneish M-Score of 1.16 suggests a lower likelihood of financial statement manipulation, reinforcing the credibility of the reported 27.0% net margins. Investors must weigh whether the high growth rate can eventually compress asset turnover or leverage requirements enough to turn the ROIC-WACC spread positive, thereby aligning current valuation multiples with long-term cash flow generation capabilities.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.4%13.4%15.4%
2%$65$53$44
3%$71$57$47
4%$79$61$50

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.4%, terminal growth 3%. Fair value $57 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
7.5
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
1.16
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

38.8%
Gross Margin
27.0%
Net Margin
11.5%
ROIC
13.4%
WACC
ROIC − WACC Spread: -1.9%— Negative spread.
+28.4%
Revenue Growth (YoY)
+773.2%
Earnings Growth (YoY)
1.0B
Free Cash Flow
17%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

27.0%
Net Profit Margin
NI ÷ Revenue
×
0.37x
Asset Turnover
Revenue ÷ Assets
×
1.39x
Equity Multiplier
Assets ÷ Equity
=
14.0%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.39x
Debt / Equity
2.69x
Current Ratio
23.5x
Interest Coverage
-0.3x
Net Debt / EBITDA
3.45%
FCF Yield
1.8B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
+$5M
Net Buying
5
Buy Transactions
20
Sale Transactions
2026-02-27Pan American Silver Corp.Other39,800 shares
2026-02-26Pan American Silver Corp.Buy$3M
2026-02-26Pan American Silver Corp.Other38,000 shares
2026-02-25Fisher, Delaney JosephSold 1/4 qtrsBuy$653
2026-02-25Pan American Silver Corp.Buy$2M

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.21
Act: $0.42
+98.8%
Q3
✓ Beat
Est: $0.40
Act: $0.43
+7.7%
Q2
✗ Miss
Est: $0.49
Act: $0.48
-2.4%
Q1
✓ Beat
Est: $0.89
Act: $1.11
+24.5%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

10.9
Forward P/E
PEG Ratio
3.12
Price/Book
1M
Avg Volume
$95.39
52W High
$29.31
52W Low
52W Range Position

PAAS.TO Capital Efficiency

How efficiently does PAAS.TO convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.0B
EBITDA
$1.8B
FCF Conversion
57%
Reinvestment Rate
43%
57% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
11.5%
ROIC − WACC Spread
-1.9%

PAAS.TO converts 57% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-1.9%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare PAAS.TO to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.